Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer

Eitemau Tebyg

• Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.
  gan: Abderrahim El Guerrab, et al.
  Cyhoeddwyd: (2011-01-01)
• Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer
  gan: Guerrab, Abderrahim El, et al.
  Cyhoeddwyd: (2016)
• Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer
  gan: El Guerrab, Abderrahim, et al.
  Cyhoeddwyd: (2017)
• Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
  gan: El Guerrab, Abderrahim, et al.
  Cyhoeddwyd: (2020)
• aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer
  gan: Cayre, Anne, et al.
  Cyhoeddwyd: (2003)